Psychotropic medication is widely prescribed to treat mental illness. However, it is controversial when used as a chemical restraint (CR) to manage challenging behaviours (CBs) of adults with intellectual disability (ID). CR has potentially negative consequences and affects human rights.
Method:
Qualitative research conducted between 2014 and 2015 explored the views of ‘guardian’ decision makers appointed under unique Queensland legislation oversighting the use of CR.
Results:
Findings included (1) negative conceptualization of CR, (2) concerning relationships with prescribers and disability sector staff, (3) challenges to information seeking about people with ID prescribed CR and (4) problematic implementation of positive behaviour support plans.
Conclusion:
According to guardians, CR may be used in lieu of community supports, and prescribers sometimes diagnose mental illness to avoid CR legislative requirements. Guardians, prescribers and professionals would benefit from training that addresses the intersection between physical and mental health, CB and CR.
AhmedZFraserWKerrMP, et al. (2000) Reducing antipsychotic medication in people with a learning disability. British Journal of Psychiatry176: 42–46.
2.
AliABlickwedelJHassiotisA (2014) Interventions for challenging behaviour in intellectual disability. Advances in Psychiatric Treatment20: 184–192.
3.
AllenD (2008) The relationship between challenging behaviour and mental ill-health in people with intellectual disabilities: a review of current theories and evidence. Journal of Intellectual Disabilities12(4): 267–294.
4.
AshcraftLAnthonyW (2008) Eliminating seclusion and restraint in recovery-oriented crisis services. Psychiatric Services59(10): 1198–1202.
Australian Law Reform Commission (2014) Equality, Capacity and Disability in Commonwealth Laws: Discussion paper. Sydney: Australian Law Reform Commission.
7.
BarbourR (2005) Making sense of focus groups. Medical Education29(7): 74–750.
8.
BensonBBrooksW (2008) Aggressive challenging behaviour and intellectual disability. Current Opinion in Psychiatry21(5): 454–458.
9.
BigwoodSCroweM (2008) “It’s part of the job, but it spoils the job”: a phenomenological study of physical restraint. International Journal of Mental Health Nursing17(3): 215–222.
10.
BraunVClarkeV (2006) Using thematic analysis in psychology. Qualitative Research in Psychology3(2): 77–101.
11.
BrylewskiJDugganL (2004) Antipsychotic medication for challenging behaviour in people with learning disability. Cochrane Database of Systematic Review3: 1–24.
CainNDavidsonPDosenA, et al. (2010) An international perspective of mental health services for people with intellectual disability. In: BourasNHoltG (eds) The Maudsley Series: Mental Health Services for Adults with Intellectual Disability: Strategies and Solutions. Hove: Psychology Press, pp. 37–53.
14.
CarrE (2007) The expanding vision of positive behaviour support: research perspectives on happiness, helpfulness and hopefulness. Journal of Positive Behaviour Interventions9(1): 4–16.
ChandlerKWillmotLWhiteB (2014) Rethinking restrictive practices: a comparative analysis. QUT Law Review14(2): 90–122.
17.
ChanJLeBelJWebberL (2012) The dollars and sense of restraints and seclusion. Journal of Law and Medicine20(1): 73–81.
18.
Commonwealth of Australia (2009) Shut Out: The Experiences of People with Disabilities and Their Families in Australia. Canberra: Commonwealth of Australia.
19.
CostelloHBourasNDavisH (2007a) The role of training in improving community care staff awareness of mental health problems in people with intellectual disabilities. Journal of Applied Research in Intellectual Disabilities20(3): 228–235.
20.
CostelloHHoltGCainN, et al. (2007b) Professional training for those working with people with intellectual disabilities and mental health problems. In BourasNHoltG (eds.) Psychiatric and Behavioural Disorders in Intellectual and Developmental Disabilities. Cambridge: Cambridge University Press, pp. 400–410.
21.
CurrierG (2003) The controversy over “chemical restraint” in acute care psychiatry. Journal of Psychiatric Practice9(1): 59–70.
22.
DebSUnwinG (2007) Psychotropic medication for behaviour problems in people with intellectual disability: a review of the current literature. Current Opinion in Psychiatry20(5): 461–466.
23.
DebSClarkeDUnwinG (2006) Using Medication to Manage Behaviour Problems Among Adults with a Learning Disability: Quick Reference Guide (QRG). London: University of Birmingham, MENCAP, The Royal College of Psychiatrists.
24.
DebSKwokHBertelliM, et al. (2009) International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities. World Psychiatry8(3): 181–186.
EdwardsNSAlexanderWMutchA (2014) Psychotropics and challenging behaviour in people with an intellectual disability. The Medical Journal of Australia200(8): 456.
27.
El-BadriSMellsopG (2008) Patient and staff perspectives on the use of seclusion. Australasian Psychiatry16(4): 248–252.
28.
EllingsonL (2009) Engaging Crystallization in Qualitative Research: An Introduction. London: SAGE Publications.
29.
EvansEHowlettSKremserT, et al. (2012) Service development for intellectual disability mental health: a human rights approach. Journal of Intellectual Disability Research56(11): 1098–1109.
30.
GaskinCMcVillyKMcGillivrayJ (2013) Initiatives to reduce the use of seclusion and restraints on people with developmental disabilities: a systematic review and quantitiative synthesis. Research in Developmental Disabilities34(11): 3946–3961.
HuangWO’BrienHRCKalinowskiCM, et al. (2007) Multidisciplinary approach to optimizing pharmacological and behavioural interventions for persons with developmental disabilities who are on psychotropic medications. Journal of Developmental and Physical Disabilities19: 237–250.
33.
KroseBRoseJHeerK, et al. (2012) Mental health services for adults with intellectual disabilities – what do service users and staff think of them?Journal of Applied Research in Intellectual Disabilities26(1): 3–13.
34.
LarueCDumaisABoyerR, et al. (2013) The experience of seclusion and restraint in psychiatric settings: perspectives of patients. Issues in Mental Health Nursing34(5): 317–324.
35.
LoweKAllenDJonesE, et al. (2007) Challenging behaviours: prevalence and topographies. Journal of Intellectual Disability Research51(8): 625–636.
36.
McGillivrayJMcCabeM (2004) Pharmacological management of challenging behaviour of individuals with intellectual disability. Research in Developmental Disabilities25(6): 523–537.
37.
Merineau-CoteJMorinD (2014) Restraint and seclusion: the perspective of service users and staff members. Journal of Applied Research in Intellectual Disabilities27(5): 447–457.
Royal Australian and New Zealand College of Psychiatrists (2011) Prescribing Psychotropic Medication to People with an Intellectual Disability: Final Report and Recommendations. Melbourne: The Royal Australian and New Zealand College of Psychiatrists.
42.
SturmeyP (2009) Restraint, seclusion and PRN medication in English services for people with learning disabilities: An analysis of the 2007 national audit survey. Journal of Applied Research in Intellectual Disabilities22: 140–144.
43.
ThakkerYBamideleKAliA, et al. (2012) Mental health and challenging behaviour: An overview of research and practice. Advances in Mental Health and Intellectual Disabilities6(5): 249–258.
TorrJJ (2013) Intellectual disability and mental ill health: a view of Australian research. Journal of Mental Health Research in Intellectual Disabilities6(2): 159–178.
46.
TorrJLennoxNCooperSA, et al. (2008) Psychiatric care of adults with intellectual disabilities: changing perceptions over a decade. Australian and New Zealand Journal of Psychiatry42(10): 890–897.
47.
TsiourisJAKimSYBrownWT, et al. (2013) Prevalence of psychotropic drug use in adults with intellectual disability: positive and negative findings from a large scale study. Journal of Autism and Developmental Disorders43: 719–731.
48.
TyrerPOliver-AfricanoPCAhmedZ, et al. (2008) Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial. Lancet371: 57–63.
WalbankS (2013) Submission to the Review of Restrictive Practices Department of Communities, Child Safety and Disability Services. Queensland: Carers Queensland Inc.
51.
WebberLDonleyMTzanakisH (2008) Chemical Restraint: What Every Disability Support Worker Needs to Know. Melbourne: State Government of Victoria.
52.
WernerSStawskiM (2012) Mental health: Knowledge, attitudes and training of professionals on dual diagnosis of intellectual disability and psychiatric disorder. Journal of Intellectual Disability Research56(3): 291–304.
